A detailed history of Wolverine Trading, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 10,500 shares of ARWR stock, worth $206,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,500
Previous 7,700 36.36%
Holding current value
$206,115
Previous $200,000 1.5%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$27.21 - $39.48 $601,857 - $873,258
-22,119 Reduced 70.09%
9,441 $270,000
Q4 2023

Feb 14, 2024

BUY
$21.2 - $31.03 $669,072 - $979,306
31,560 New
31,560 $965,000
Q1 2022

May 16, 2022

BUY
$39.62 - $69.97 $228,567 - $403,656
5,769 New
5,769 $263,000
Q2 2020

Aug 13, 2020

SELL
$26.12 - $43.27 $398,225 - $659,694
-15,246 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$20.56 - $63.12 $107,302 - $329,423
5,219 Added 52.05%
15,246 $442,000
Q4 2019

Feb 12, 2020

BUY
$28.14 - $73.01 $67,789 - $175,881
2,409 Added 31.62%
10,027 $644,000
Q3 2019

Nov 14, 2019

SELL
$26.26 - $34.86 $807,600 - $1.07 Million
-30,754 Reduced 80.15%
7,618 $205,000
Q2 2019

Aug 20, 2019

BUY
$17.43 - $28.82 $338,630 - $559,914
19,428 Added 102.55%
38,372 $1.02 Million
Q1 2019

May 15, 2019

SELL
$12.05 - $20.18 $132,706 - $222,242
-11,013 Reduced 36.76%
18,944 $348,000
Q4 2018

Feb 14, 2019

SELL
$10.74 - $19.7 $92,943 - $170,483
-8,654 Reduced 22.41%
29,957 $358,000
Q3 2017

Nov 15, 2017

BUY
$1.69 - $4.33 $65,252 - $167,185
38,611
38,611 $167,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.08B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.